Kardiocentrum Nitra, s.r.o.
About Kardiocentrum Nitra, s.r.o.
"Poskytujeme špičkové medicínske služby v oblasti prevencie, diagnostiky a liečby kardiovaskulárnych chorôb v súlade s najnovšími vedeckými poznatkami. Poskytujeme intervenčné výkony v non-stop prevádzke 24 hodín / 7 dní v týždni. Kardiocentrum Nitra vám ponúka špičkové medicínske služby od roku 2007."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Bayer
2
Pfizer
2
Gilead Sciences
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Kardiocentrum Nitra, s.r.o.
During the past decade, Kardiocentrum Nitra, s.r.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
2010-09-01
2012-10-01
Completed
1,012
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
2011-09-01
2012-10-01
Completed
949
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kardiocentrum Nitra, s.r.o." #1 sponsor was "Amgen" with 2 trials, followed by "Bayer" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Kardiocentrum Nitra, s.r.o.
According to Clinical.Site data, the most researched conditions in "Kardiocentrum Nitra, s.r.o." are
"Cardiovascular Disease" (2 trials), "Angina Pectoris" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Kardiocentrum Nitra, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at Kardiocentrum Nitra, s.r.o.
Most popular intervention types in "Kardiocentrum Nitra, s.r.o." are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kardiocentrum Nitra, s.r.o.
The vast majority of trials in "Kardiocentrum Nitra, s.r.o." are
8 trials for "All" genders.
Clinical Trials Status at Kardiocentrum Nitra, s.r.o.
Currently, there are NaN active trials in "Kardiocentrum Nitra, s.r.o.".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kardiocentrum Nitra, s.r.o.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kardiocentrum Nitra, s.r.o., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".